---
layout: default
title: ProstNFound+: A Prospective Study using Medical Foundation Models for Prostate Cancer Detection
---

# ProstNFound+: A Prospective Study using Medical Foundation Models for Prostate Cancer Detection

<div class="paper-toolbar">
  <div class="toolbar-left">
    <a href="https://arxiv.org/abs/2510.26703" target="_blank" class="toolbar-btn">arXiv: 2510.26703v1</a>
    <a href="https://arxiv.org/pdf/2510.26703.pdf" target="_blank" class="toolbar-btn">PDF</a>
  </div>
  <div class="toolbar-right">
    <button class="toolbar-btn favorite-btn" data-arxiv-id="2510.26703v1" 
            onclick="toggleFavorite(this, '2510.26703v1', 'ProstNFound+: A Prospective Study using Medical Foundation Models for Prostate Cancer Detection')" title="Êî∂Ëóè">
      ‚òÜ Êî∂Ëóè
    </button>
    <button class="toolbar-btn share-btn" onclick="copyLink()" title="Â§çÂà∂ÈìæÊé•">
      üîó ÂàÜ‰∫´
    </button>
  </div>
</div>


**‰ΩúËÄÖ**: Paul F. R. Wilson, Mohamed Harmanani, Minh Nguyen Nhat To, Amoon Jamzad, Tarek Elghareb, Zhuoxin Guo, Adam Kinnaird, Brian Wodlinger, Purang Abolmaesumi, Parvin Mousavi

**ÂàÜÁ±ª**: eess.IV, cs.CV

**ÂèëÂ∏ÉÊó•Êúü**: 2025-10-30

---

## üí° ‰∏ÄÂè•ËØùË¶ÅÁÇπ

**ProstNFound+ÔºöÂà©Áî®ÂåªÂ≠¶Âü∫Á°ÄÊ®°ÂûãÂÆûÁé∞ÂâçÂàóËÖ∫ÁôåÂæÆË∂ÖÂ£∞Ê£ÄÊµãÁöÑÂâçÁûªÊÄßÁ†îÁ©∂**

üéØ **ÂåπÈÖçÈ¢ÜÂüü**: **ÊîØÊü±‰πùÔºöÂÖ∑Ë∫´Â§ßÊ®°Âûã (Embodied Foundation Models)**

**ÂÖ≥ÈîÆËØç**: `ÂâçÂàóËÖ∫ÁôåÊ£ÄÊµã` `ÂåªÂ≠¶Âü∫Á°ÄÊ®°Âûã` `ÂæÆË∂ÖÂ£∞` `ÈÄÇÈÖçÂô®Ë∞É‰ºò` `ÊèêÁ§∫Â≠¶‰π†` `ÂâçÁûªÊÄßÁ†îÁ©∂` `‰∏¥Â∫äÂ∫îÁî®`

## üìã Ê†∏ÂøÉË¶ÅÁÇπ

1. Áé∞ÊúâÂâçÂàóËÖ∫ÁôåÊ£ÄÊµãÊñπÊ≥ï‰æùËµñ‰∏ìÂÆ∂ÁªèÈ™åÔºåÂ≠òÂú®‰∏ªËßÇÊÄßÂíåÂèØÊâ©Â±ïÊÄßÈóÆÈ¢òÔºåÁº∫‰πèÂÆ¢ËßÇ„ÄÅÈ´òÊïàÁöÑËØäÊñ≠Â∑•ÂÖ∑„ÄÇ
2. ProstNFound+Âà©Áî®ÂåªÂ≠¶Âü∫Á°ÄÊ®°ÂûãÔºåÁªìÂêàÈÄÇÈÖçÂô®Ë∞É‰ºòÂíåÂÆöÂà∂ÊèêÁ§∫ÁºñÁ†ÅÂô®ÔºåÂµåÂÖ•‰∏¥Â∫äÁîüÁâ©Ê†áÂøóÁâ©ÔºåÁîüÊàêÁôåÁóáÁÉ≠ÂõæÂíåÈ£éÈô©ËØÑÂàÜ„ÄÇ
3. ÂâçÁûªÊÄßÁ†îÁ©∂Ë°®ÊòéÔºåProstNFound+ÂÖ∑ÊúâËâØÂ•ΩÁöÑÊ≥õÂåñËÉΩÂäõÔºå‰∏é‰∏¥Â∫äËØÑÂàÜ‰∏ÄËá¥ÔºåÂπ∂ÁîüÊàêÂèØËß£ÈáäÁöÑÁÉ≠ÂõæÔºåÂÖ∑Êúâ‰∏¥Â∫äÈÉ®ÁΩ≤ÊΩúÂäõ„ÄÇ

## üìù ÊëòË¶ÅÔºà‰∏≠ÊñáÔºâ

Êú¨Á†îÁ©∂Êó®Âú®Êé¢Á¥¢ÂåªÂ≠¶Âü∫Á°ÄÊ®°ÂûãÔºàFMsÔºâÂú®ÊûÑÂª∫È´òÊÄßËÉΩËØäÊñ≠Á≥ªÁªü‰∏≠ÁöÑÊΩúÂäõÔºåÂπ∂È¶ñÊ¨°Âú®‰∏¥Â∫äÁéØÂ¢É‰∏≠ÊµãËØïÂÖ∂Âú®ÂâçÂàóËÖ∫ÁôåÔºàPCaÔºâÂæÆË∂ÖÂ£∞ÔºàŒºUSÔºâÊ£ÄÊµã‰∏≠ÁöÑÂ∫îÁî®„ÄÇÊàë‰ª¨ÊèêÂá∫‰∫ÜProstNFound+Ôºå‰∏Ä‰∏™ÈíàÂØπŒºUSÁöÑPCaÊ£ÄÊµãÁöÑFMÊîπËøõÊ®°ÂûãÔºåÂπ∂ÂØπÂÖ∂ËøõË°å‰∫ÜÈ¶ñÊ¨°ÂâçÁûªÊÄßÈ™åËØÅ„ÄÇProstNFound+ÁªìÂêà‰∫ÜÂåªÂ≠¶FM„ÄÅÈÄÇÈÖçÂô®Ë∞É‰ºòÂíå‰∏Ä‰∏™ÂÆöÂà∂ÁöÑÊèêÁ§∫ÁºñÁ†ÅÂô®ÔºåËØ•ÁºñÁ†ÅÂô®ÂµåÂÖ•‰∫ÜPCaÁâπÂºÇÊÄßÁöÑ‰∏¥Â∫äÁîüÁâ©Ê†áÂøóÁâ©„ÄÇËØ•Ê®°ÂûãÁîüÊàêÁôåÁóáÁÉ≠ÂõæÂíå‰∏¥Â∫äÊòæËëóPCaÁöÑÈ£éÈô©ËØÑÂàÜ„ÄÇÂú®Â§ö‰∏≠ÂøÉÂõûÈ°æÊÄßÊï∞ÊçÆ‰∏äËÆ≠ÁªÉÂêéÔºåËØ•Ê®°ÂûãÂú®‰∫îÂπ¥Âêé‰ªé‰∏Ä‰∏™Êñ∞ÁöÑ‰∏¥Â∫äÁ´ôÁÇπËé∑ÂæóÁöÑÊï∞ÊçÆ‰∏äËøõË°åÂâçÁûªÊÄßËØÑ‰º∞„ÄÇÊ®°ÂûãÈ¢ÑÊµã‰∏éÊ†áÂáÜ‰∏¥Â∫äËØÑÂàÜÂçèËÆÆÔºàPRI-MUSÂíåPI-RADSÔºâËøõË°åÂü∫ÂáÜÊµãËØï„ÄÇÁªìÊûúË°®ÊòéÔºåProstNFound+ÂØπÂâçÁûªÊÄßÊï∞ÊçÆË°®Áé∞Âá∫Âº∫Â§ßÁöÑÊ≥õÂåñËÉΩÂäõÔºå‰∏éÂõûÈ°æÊÄßËØÑ‰º∞Áõ∏ÊØîÊ≤°ÊúâÊÄßËÉΩ‰∏ãÈôç„ÄÇÂÆÉ‰∏é‰∏¥Â∫äËØÑÂàÜÂØÜÂàáÁõ∏ÂÖ≥ÔºåÂπ∂‰∫ßÁîü‰∏éÊ¥ªÊ£ÄÁ°ÆËÆ§ÁöÑÁóÖÂèò‰∏ÄËá¥ÁöÑÂèØËß£ÈáäÁÉ≠Âõæ„ÄÇÁªìÊûúÁ™ÅÂá∫‰∫ÜÂÖ∂‰∏¥Â∫äÈÉ®ÁΩ≤ÁöÑÊΩúÂäõÔºå‰∏∫‰∏ìÂÆ∂È©±Âä®ÁöÑÂçèËÆÆÊèê‰æõ‰∫Ü‰∏ÄÁßçÂèØÊâ©Â±ï‰∏îÂèØËß£ÈáäÁöÑÊõø‰ª£ÊñπÊ°à„ÄÇ

## üî¨ ÊñπÊ≥ïËØ¶Ëß£

**ÈóÆÈ¢òÂÆö‰πâ**ÔºöËÆ∫ÊñáÊó®Âú®Ëß£ÂÜ≥ÂâçÂàóËÖ∫ÁôåÂæÆË∂ÖÂ£∞ÂõæÂÉèÔºàŒºUSÔºâÊ£ÄÊµã‰∏≠ÔºåÁé∞ÊúâÊñπÊ≥ï‰æùËµñ‰∏ìÂÆ∂ÁªèÈ™å„ÄÅ‰∏ªËßÇÊÄßÂº∫„ÄÅÂèØÊâ©Â±ïÊÄßÂ∑ÆÁöÑÈóÆÈ¢ò„ÄÇÁé∞ÊúâÊñπÊ≥ïÈöæ‰ª•ÂÖÖÂàÜÂà©Áî®‰∏¥Â∫äÁîüÁâ©Ê†áÂøóÁâ©Ôºå‰∏îÁº∫‰πèÂØπÊñ∞‰∏¥Â∫äÁéØÂ¢ÉÁöÑÊ≥õÂåñËÉΩÂäõ„ÄÇ

**Ê†∏ÂøÉÊÄùË∑Ø**ÔºöËÆ∫ÊñáÁöÑÊ†∏ÂøÉÊÄùË∑ØÊòØÂà©Áî®ÂåªÂ≠¶Âü∫Á°ÄÊ®°ÂûãÔºàFMsÔºâÁöÑÂº∫Â§ßË°®ÂæÅËÉΩÂäõÔºåÈÄöËøáÈÄÇÈÖçÂô®Ë∞É‰ºòÂíåÂÆöÂà∂ÊèêÁ§∫ÁºñÁ†ÅÂô®ÔºåÂ∞Ü‰∏¥Â∫äÁîüÁâ©Ê†áÂøóÁâ©ËûçÂÖ•Ê®°ÂûãÔºå‰ªéËÄåÊèêÈ´òÂâçÂàóËÖ∫ÁôåÊ£ÄÊµãÁöÑÂáÜÁ°ÆÊÄßÂíåÊ≥õÂåñËÉΩÂäõ„ÄÇËøôÁßçÊñπÊ≥ïÊó®Âú®ÂáèÂ∞ëÂØπ‰∏ìÂÆ∂ÁªèÈ™åÁöÑ‰æùËµñÔºåÂπ∂Êèê‰æõÊõ¥ÂÆ¢ËßÇ„ÄÅÂèØËß£ÈáäÁöÑËØäÊñ≠ÁªìÊûú„ÄÇ

**ÊäÄÊúØÊ°ÜÊû∂**ÔºöProstNFound+ÁöÑÊï¥‰ΩìÊû∂ÊûÑÂåÖÊã¨‰∏â‰∏™‰∏ªË¶ÅÊ®°ÂùóÔºö1) ÂåªÂ≠¶Âü∫Á°ÄÊ®°ÂûãÔºàMedical FMÔºâÔºöÂà©Áî®È¢ÑËÆ≠ÁªÉÁöÑÂåªÂ≠¶ÂõæÂÉèÊ®°Âûã‰Ωú‰∏∫ÁâπÂæÅÊèêÂèñÂô®„ÄÇ2) ÈÄÇÈÖçÂô®Ë∞É‰ºòÔºàAdapter TuningÔºâÔºöÈÄöËøáÂ∞ëÈáèÊï∞ÊçÆÂæÆË∞ÉFMÔºå‰ΩøÂÖ∂ÈÄÇÂ∫îÂâçÂàóËÖ∫ÁôåŒºUSÂõæÂÉèÁöÑÁâπÁÇπ„ÄÇ3) ÊèêÁ§∫ÁºñÁ†ÅÂô®ÔºàPrompt EncoderÔºâÔºöÂ∞ÜPCaÁâπÂºÇÊÄßÁöÑ‰∏¥Â∫äÁîüÁâ©Ê†áÂøóÁâ©ÁºñÁ†Å‰∏∫ÊèêÁ§∫‰ø°ÊÅØÔºåÂºïÂØºÊ®°ÂûãÂÖ≥Ê≥®ÂÖ≥ÈîÆÂå∫Âüü„ÄÇÊ®°ÂûãÊúÄÁªàÁîüÊàêÁôåÁóáÁÉ≠ÂõæÂíåÈ£éÈô©ËØÑÂàÜ„ÄÇ

**ÂÖ≥ÈîÆÂàõÊñ∞**ÔºöËØ•ËÆ∫ÊñáÁöÑÂÖ≥ÈîÆÂàõÊñ∞Âú®‰∫éÂ∞ÜÂåªÂ≠¶Âü∫Á°ÄÊ®°Âûã‰∏éÈÄÇÈÖçÂô®Ë∞É‰ºòÂíåÂÆöÂà∂ÊèêÁ§∫ÁºñÁ†ÅÂô®Áõ∏ÁªìÂêàÔºåÁî®‰∫éÂâçÂàóËÖ∫ÁôåÂæÆË∂ÖÂ£∞ÂõæÂÉèÁöÑÊ£ÄÊµã„ÄÇÈÄöËøáÊèêÁ§∫ÁºñÁ†ÅÂô®ÂµåÂÖ•‰∏¥Â∫äÁîüÁâ©Ê†áÂøóÁâ©ÔºåÂ¢ûÂº∫‰∫ÜÊ®°ÂûãÁöÑÂà§Âà´ËÉΩÂäõÂíåÂèØËß£ÈáäÊÄß„ÄÇÊ≠§Â§ñÔºåËØ•Á†îÁ©∂ËøõË°å‰∫ÜÂâçÁûªÊÄßÈ™åËØÅÔºåËØÅÊòé‰∫ÜÊ®°ÂûãÂú®Êñ∞ÁöÑ‰∏¥Â∫äÁéØÂ¢É‰∏≠ÁöÑÊ≥õÂåñËÉΩÂäõ„ÄÇ

**ÂÖ≥ÈîÆËÆæËÆ°**ÔºöÊèêÁ§∫ÁºñÁ†ÅÂô®ÁöÑËÆæËÆ°ÊòØÂÖ≥ÈîÆ„ÄÇÂÆÉÂ∞Ü‰∏¥Â∫äÁîüÁâ©Ê†áÂøóÁâ©Ôºà‰æãÂ¶ÇÔºåËÇøÁò§Â§ßÂ∞è„ÄÅ‰ΩçÁΩÆ„ÄÅÂΩ¢ÊÄÅÁ≠âÔºâÁºñÁ†ÅÊàêÂêëÈáèÔºåÂπ∂Â∞ÜÂÖ∂‰Ωú‰∏∫ÊèêÁ§∫‰ø°ÊÅØËæìÂÖ•Âà∞ÂåªÂ≠¶Âü∫Á°ÄÊ®°Âûã‰∏≠„ÄÇÈÄÇÈÖçÂô®Ë∞É‰ºòÈááÁî®Â∞ëÈáèÊï∞ÊçÆËøõË°åÂæÆË∞ÉÔºåÈÅøÂÖç‰∫ÜÁÅæÈöæÊÄßÈÅóÂøò„ÄÇÊçüÂ§±ÂáΩÊï∞ÂåÖÊã¨ÂàÜÁ±ªÊçüÂ§±ÔºàÂå∫ÂàÜÁôåÊÄßÂíåÈùûÁôåÊÄßÂå∫ÂüüÔºâÂíåÂõûÂΩíÊçüÂ§±ÔºàÈ¢ÑÊµãÈ£éÈô©ËØÑÂàÜÔºâ„ÄÇÂÖ∑‰ΩìÁΩëÁªúÁªìÊûÑÁªÜËäÇÊú™Áü•„ÄÇ

## üìä ÂÆûÈ™å‰∫ÆÁÇπ

ProstNFound+Âú®ÂâçÁûªÊÄßÊï∞ÊçÆ‰∏äË°®Áé∞Âá∫Âº∫Â§ßÁöÑÊ≥õÂåñËÉΩÂäõÔºå‰∏éÂõûÈ°æÊÄßËØÑ‰º∞Áõ∏ÊØîÊ≤°ÊúâÊÄßËÉΩ‰∏ãÈôç„ÄÇÊ®°ÂûãÈ¢ÑÊµã‰∏éÊ†áÂáÜ‰∏¥Â∫äËØÑÂàÜÂçèËÆÆÔºàPRI-MUSÂíåPI-RADSÔºâÂØÜÂàáÁõ∏ÂÖ≥ÔºåÂπ∂ÁîüÊàê‰∏éÊ¥ªÊ£ÄÁ°ÆËÆ§ÁöÑÁóÖÂèò‰∏ÄËá¥ÁöÑÂèØËß£ÈáäÁÉ≠Âõæ„ÄÇËøô‰∫õÁªìÊûúË°®ÊòéProstNFound+ÂÖ∑Êúâ‰∏¥Â∫äÈÉ®ÁΩ≤ÁöÑÊΩúÂäõ„ÄÇ

## üéØ Â∫îÁî®Âú∫ÊôØ

ProstNFound+ÂèØÂ∫îÁî®‰∫éÂâçÂàóËÖ∫ÁôåÁöÑÊó©ÊúüÁ≠õÊü•ÂíåËØäÊñ≠ÔºåËæÖÂä©ÂåªÁîüËøõË°åÂÜ≥Á≠ñÔºåÊèêÈ´òËØäÊñ≠ÂáÜÁ°ÆÊÄßÂíåÊïàÁéá„ÄÇËØ•Ê®°ÂûãÂÖ∑ÊúâÂèØÊâ©Â±ïÊÄßÔºåÂèØÈÉ®ÁΩ≤Âú®‰∏çÂêåÁöÑ‰∏¥Â∫äÁéØÂ¢É‰∏≠Ôºå‰∏∫ÊÇ£ËÄÖÊèê‰æõÊõ¥‰æøÊç∑„ÄÅÂÆ¢ËßÇÁöÑËØäÊñ≠ÊúçÂä°„ÄÇÊú™Êù•ÔºåËØ•Ê®°ÂûãÂèØ‰∏éÂÖ∂‰ªñ‰∏¥Â∫äÊï∞ÊçÆÔºàÂ¶ÇMRI„ÄÅÊ¥ªÊ£ÄÁªìÊûúÔºâÁªìÂêàÔºåÂÆûÁé∞Êõ¥ÂÖ®Èù¢ÁöÑÂâçÂàóËÖ∫ÁôåÈ£éÈô©ËØÑ‰º∞„ÄÇ

## üìÑ ÊëòË¶ÅÔºàÂéüÊñáÔºâ

> Purpose: Medical foundation models (FMs) offer a path to build high-performance diagnostic systems. However, their application to prostate cancer (PCa) detection from micro-ultrasound (ŒºUS) remains untested in clinical settings. We present ProstNFound+, an adaptation of FMs for PCa detection from ŒºUS, along with its first prospective validation. Methods: ProstNFound+ incorporates a medical FM, adapter tuning, and a custom prompt encoder that embeds PCa-specific clinical biomarkers. The model generates a cancer heatmap and a risk score for clinically significant PCa. Following training on multi-center retrospective data, the model is prospectively evaluated on data acquired five years later from a new clinical site. Model predictions are benchmarked against standard clinical scoring protocols (PRI-MUS and PI-RADS). Results: ProstNFound+ shows strong generalization to the prospective data, with no performance degradation compared to retrospective evaluation. It aligns closely with clinical scores and produces interpretable heatmaps consistent with biopsy-confirmed lesions. Conclusion: The results highlight its potential for clinical deployment, offering a scalable and interpretable alternative to expert-driven protocols.

